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To the Editor: We report results 
of the prospective surveillance system 
established in the largest intensive 
care unit (ICU) of Reunion Island (25 
beds). This system covers 500,000 
residents (62% of the total population) 
and monitors the daily status of patients 
>17 years of age who had a positive 
reverse transcription–PCR (RT-PCR) 
for pandemic (H1N1) 2009 virus. Re-
union Island is a French overseas terri-
tory in the Southern Hemisphere, with 
health care facilities similar to those 
of mainland France. Patients were fol-
lowed up until discharge from the ICU 
or death. Data were collected during 
July 15–September 30, 2009.
Of 148 patients with conﬁ  rmed 
pandemic (H1N1) 2009 infection 
admitted to the hospital, 13 (9%) pa-
tients (8 female) were admitted to the 
ICU. These corresponded to 7% of all 
187 patients admitted to the ICU dur-
ing the same period. Median age was 
39.4 (±19) years (range 17–69 years). 
Ten patients were admitted for respi-
ratory failure related to viral pneu-
monitis, 1 for pulmonary edema with 
severe chronic coronary insufﬁ  ciency, 
1 for congenital adrenal insufﬁ  ciency 
with reversible multiple organ failure, 
and 1 for status epilepticus. Eleven 
(85%) patients had underlying concur-
rent medical conditions: 3 were over-
weight (body mass indexes 38, 32, and 
29.3 kg/m2); 1 was pregnant and had 
asthma.
Four (31%) patients died. One 
was a 28-year-old woman with ce-
rebral motor inﬁ   rmity and severe 
chronic restrictive respiratory failure. 
An 18-year-old woman with aplasia 
after receipt of an allograft for Hodg-
kin lymphoma died of cerebral hemor-
rhage while receiving extracorporeal 
membrane oxygenation. A 52-year-
old man admitted for pulmonary ede-
ma with severe coronary insufﬁ  ciency 
died of multiple organ failure. A 33-
year-old man with no known concur-
rent medical conditions died of acute 
respiratory distress syndrome. Time 
from ICU admission to death ranged 
from 15 to 85 days (mean 36.5 ± 32 
days). Mean age of patients who died 
was 32.5 ± 14.3 years.
Chest radiographic ﬁ  ndings were 
abnormal for all patients except 1, who 
was admitted for fever and convul-
sions (Huntington chorea). Bilateral 
pulmonary embolism was conﬁ  rmed 
in an obese patient who survived.
Mean time between onset of clini-
cal signs and ICU admission was 6.9 ± 
3.2 days. Mean time between admis-
sion to ICU with diagnosis conﬁ  rmed 
by RT-PCR and initiation of antivi-
ral treatment was 1.8 ± 1.7 days and 
between illness onset and initiation 
of antiviral treatment, 8.8 ± 3 days 
(range 4–16 days). Mean length of 
ICU stay was 26.3 ± 29.3 days. Pa-
tients remained in the ICU for a total 
of 201 bed-days (402 per million resi-
dents). The maximum daily occupan-
cy of the ICU was 10 beds per million 
residents.
Five patients received steroids 
for severe hypotension or asthma-like 
clinical illness. Severe hypotension 
developed in 5 patients, and they re-
ceived vasopressors. No patient re-
ceived intravenous immunoglobulins. 
Ten (77%) patients required mechani-
cal ventilation for a median of 11.5 ± 
12.2 days. One patient required high-
frequency ventilation, 3 required ex-
tracorporeal membrane oxygenation, 
and 1 required hemodialysis. Multiple 
organ failure developed in 3. All pa-
tients were empirically given anti-
bacterial drugs. Secondary infections 
were either documented or strongly 
suspected for 5 patients.
All patients received oral oselta-
mivir beginning 4–16 days after ill-
ness onset and continuing for 2–17 
days (mean 7.2 ± 4.3). Zanamivir 
was administered 1 time by inhala-
tion through the ventilator. Viral loads 
in respiratory specimens ranged from 
4 × 103 to 6.9 × 107 copies/mL (mean 
1.4 × 105). Two patients excreted virus 
in their bronchoalveolar lavage speci-
mens for a prolonged time (14 days).
The most prominent biological 
ﬁ  ndings were elevated serum levels of 
procalcitonin, C-reactive protein, as-
partate aminotransferase, alanine ami-
notransferase, lactate dehydrogenase, 
and creatine kinase. Eight patients had 
lymphopenia (<1,200 cells/mm3).
Our ﬁ  ndings are consistent with 
ﬁ  ndings of other studies of severe or 
fatal viral pneumonia in younger pa-
tients than are usually affected in a 
normal inﬂ   uenza season (1–4), par-
ticularly in patients with concurrent 
medical conditions. In our study, the 3 
overweight patients survived. Obesity 
is associated with increased severity of 
illness, but not always with death, in 
critically ill patients (5). We conﬁ  rm 
that previously healthy young persons 
can die of pandemic (H1N1) 2009, 
although at a much lower rate than 
those infected in the initial outbreaks 
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in Mexico (6) and the United States 
(7). In the United States, several preg-
nant women died, and the hospitaliza-
tion rate for pregnant women was 4× 
higher than for the general population 
(8). Despite a fairly high birth rate on 
Reunion Island (19 births/1,000 popu-
lation), our small series does not sup-
port these ﬁ  ndings.
During the epidemic (July 20–
September 20, 2009), acute respiratory 
infections, including presumed cases 
of pandemic (H1N1) 2009, accounted 
for 20.6% of the total case load of 
physicians on the island. The attack 
rate was ≈12.9% among the 810,000 
inhabitants, and 8 deaths among per-
sons with conﬁ  rmed infection were re-
ported. Therefore, the minimal overall 
death rate was ≈7.5 per million popu-
lation and the case-fatality rate, 1 per 
10,000 population.
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To the Editor: Crimean-Congo 
hemorrhagic fever virus (CCHFV) 
causes a disease in humans that is 
characterized by fever and hemorrhag-
ic manifestations, with death rates up 
to 30%. Humans are infected through 
tick bites or contact with the viremic 
blood of patients or livestock. CCHFV 
belongs to the genus Nairovirus (fam-
ily  Bunyaviridae), which contains 7 
serogroups: CCHFV, Dugbe virus, 
Hughes virus, Sakhalin virus, Dera 
Ghazi Khan virus, Qalyub virus, and 
Thiafora virus.
A CCHFV strain, AP92, was iso-
lated from Rhipicephalus bursa ticks 
collected in 1975 from goats in Vergi-
na, a village in northern Greece (1). Se-
roprevalence among Vergina residents 
was 6.1% (2). During 1981–1988, the 
seroprevalence among 3,388 persons 
in Greece was 1.1% (range 0%–9.6%) 
(3). The ﬁ  rst Crimean-Congo hemor-
rhagic fever case in Greece was re-
ported in 2008, when a woman died in 
Komotini in northeastern Greece (4). 
The causative strain (Rodopi) differs 
from strain AP92 (5).
To determine the prevalence of 
CCHFV antibodies in the human 
population of northeastern Greece, se-
rum samples were collected prospec-
tively during November 2008–April 
2009 from 1,178 residents of Drama, 
Kavala, Xanthi, Rodopi, and Evros 
prefectures. A predeﬁ  ned number of 
participants were enrolled in the study 
on the basis of prefecture population. 
Participants were selected randomly 
among persons who were referred to 
health care settings for blood testing, 
regardless of reason for testing, and re-
gardless of CCHFV risk factors. Oral 
consent was given by all participants. 
A questionnaire was completed con-
cerning age, sex, occupation, place of 
residence, history of tick bite, symp-
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